Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction.
about
Insulin: a wonder drug in the critically ill?Ischaemic conditioning: pitfalls on the path to clinical translationThe Influence of Diabetes Mellitus in Myocardial Ischemic PreconditioningEndoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transitionDiabetic cardiomyopathy: pathophysiology and clinical featuresPre-infarction angina and outcomes in non-ST-segment elevation myocardial infarction: data from the RICO survey.Ischemic conditioning: the challenge of protecting the diabetic heart.The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities.AMPK-regulated and Akt-dependent enhancement of glucose uptake is essential in ischemic preconditioning-alleviated reperfusion injuryHypotheses, rationale, design, and methods for evaluation of ischemic preconditioning assessed by sequential exercise tests in diabetic and non-diabetic patients with stable coronary artery disease--a prospective study.Understanding myocardial ischemic preconditioning, and the implications for a role of adenosine catabolism.Diabetes and cardiovascular disease: the road to cardioprotection.C1q-TNF-related protein-9, a novel cardioprotetcive cardiokine, requires proteolytic cleavage to generate a biologically active globular domain isoform.Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients.Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside?The Loss of Myocardial Benefit following Ischemic Preconditioning Is Associated with Dysregulation of Iron Homeostasis in Diet-Induced Diabetes.The role of comorbidities in cardioprotectionEffects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning.The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes.Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation.Long-term clinical outcome of ST-segment elevation myocardial infarction patients with and without diabetes mellitus in the Zwolle trialIn vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycineType 2 diabetes, mitochondrial biology and the heart.Preconditioning the diabetic human myocardiumHigh Glucose Attenuates Anesthetic Cardioprotection in Stem-Cell-Derived Cardiomyocytes: The Role of Reactive Oxygen Species and Mitochondrial FissionEfficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.Problem of the insulin resistance in surgery.Remote ischaemic conditioning-therapeutic opportunities in renal medicine.What is hormesis and its relevance to healthy aging and longevity?Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC Trial.Remote ischaemic conditioning and remodelling following myocardial infarction: current evidence and future perspectives.Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling.Vasonatrin peptide attenuates myocardial ischemia-reperfusion injury in diabetic rats and underlying mechanisms.Glutathione administration reduces mitochondrial damage and shifts cell death from necrosis to apoptosis in ageing diabetic mice hearts during exercise.Metformin Protects H9C2 Cardiomyocytes from High-Glucose and Hypoxia/Reoxygenation Injury via Inhibition of Reactive Oxygen Species Generation and Inflammatory Responses: Role of AMPK and JNK.Ischaemic preconditioning effect of prodromal angina pectoris is lost in patients with prior myocardial infarction.Isoflurane-induced preconditioning is attenuated by diabetes.Effect of acute hyperglycaemia and diabetes mellitus with and without short-term insulin treatment on myocardial ischaemic late preconditioning in the rabbit heart in vivo.Coronary blood flow in evolving myocardial infarction preceded by preinfarction angina: a critical reevaluation of preconditioning effects in clinical cases.Myocardium tolerant to an adenosine-dependent ischemic preconditioning stimulus can still be protected by stimuli that employ alternative signaling pathways.
P2860
Q24796369-1F3F3EE0-B3C5-4E81-BE48-8663945F4E65Q27000466-6FF264CE-873C-41DE-BEC5-75698B6B9A9CQ28080349-9A69867D-6800-43E6-BD68-83BF6827A2FAQ28577217-8E5ABA27-EE3A-44D3-9835-A105E7F34471Q30457504-37F34F65-CDC5-4DCB-A812-ADC687907CE6Q30583477-9246B462-BAE2-4F5C-8669-174AFF068241Q34457775-2AECD080-B1D0-4725-AEAF-7ADD25BCB50EQ34637342-7F0DFDEA-4A17-4CCC-8E27-0A4783F86FD6Q34904750-16C7F4E0-B858-4E31-A1FE-A82D01B6F4B4Q35065088-F66121B7-77BF-4A96-8610-7CB8074FF20AQ35072009-1C3EB36B-5130-4417-9179-3C8C59C566E3Q35585114-152F915C-06B2-4CF5-B997-E1A218126634Q35622442-8651C74D-D936-42A3-8CDB-E9A44CD43CBCQ35672947-A6E2750E-8386-4145-B05B-82CEB9172CCCQ35741598-9DAC22D4-CEFA-432D-AECC-6BB5A6C29BB8Q36085711-7EC30039-D1AE-4F2A-B257-EA9676E114D2Q36099360-7A90AFDB-25DE-4A95-9B0E-9CB0EF2BA953Q36288965-09BD9F2B-9921-4B68-952F-880B378931D2Q36333927-DF88FDAA-E417-46AE-9131-D82570B665A2Q36720378-5FC97C67-1168-430A-AC1E-747BCC97712CQ36817657-0632641E-EA4E-4314-BD28-9B0C397B9B04Q37195014-45DD9257-4888-4631-89C2-CE92753039E0Q37195072-8417AAA1-122F-47FD-BF3B-1F9A094AD5EDQ37311040-0158DA66-7A7B-43CA-B6C6-92AA4EF506F3Q37536275-BA24BC40-1A1C-4A58-92A7-D160337A13B2Q37871976-3195F420-2F61-49AA-86BB-16A54421DD78Q37968100-771FC6F0-680A-4C61-A5BF-5BE7A31BE3CBQ38159918-5492A4AF-0AB1-4818-9546-B8D8B32AA2B6Q38582970-3D4D7A48-B27F-4D5A-8912-D79DD98B2F9EQ38637360-6AB4EFDF-387E-441E-8D79-1EF32AB34FF5Q38833919-05E6D7AE-3872-4F93-A7A0-94B8A6D95B6BQ38890008-ABD1B555-3200-4245-959F-A895A95FF9CAQ38931035-74DA6535-9974-4A00-A290-FDF8E3DBE84AQ38974021-DB893392-63DB-45CD-96C4-025BAC9AB680Q42753055-A2E8E841-2ABA-49B6-AA2C-E3CA72606FE7Q42833304-F79B2F59-91E2-4099-B598-3C2AD2B8F2CDQ43988545-5084C9C0-327E-41E9-94B8-851D4C11D5B5Q44435529-C96D7823-F449-42C8-8A7F-EFDA5BF46667Q44753298-3B0917A3-08AF-4B52-956A-7867C8BD8059Q45107978-ABF19BEB-80C5-4F3A-841A-B6CD377A07BE
P2860
Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Diabetes mellitus prevents isc ...... or wall myocardial infarction.
@en
Diabetes mellitus prevents isc ...... or wall myocardial infarction.
@nl
type
label
Diabetes mellitus prevents isc ...... or wall myocardial infarction.
@en
Diabetes mellitus prevents isc ...... or wall myocardial infarction.
@nl
prefLabel
Diabetes mellitus prevents isc ...... or wall myocardial infarction.
@en
Diabetes mellitus prevents isc ...... or wall myocardial infarction.
@nl
P2093
P1476
Diabetes mellitus prevents isc ...... or wall myocardial infarction.
@en
P2093
Ishihara M
Nakamura S
Nishioka K
Shimatani Y
P304
P356
10.1016/S0735-1097(01)01477-2
P407
P577
2001-10-01T00:00:00Z